bf/NASDAQ:MRSN_icon.jpeg

COM:MERSANA

Mersana Therapeutics

  • Stock

USD

Last Close

1.98

22/11 21:00

Market Cap

239.83M

Beta: -

Volume Today

587.87K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-2.09M
-
-2.09M
0%
average payables
2.05M
-
2.57M
25.53%
6.90M
168.53%
9.01M
30.63%
7.82M
13.24%
10.33M
32.14%
13.14M
27.16%
10.63M
19.04%
average receivables
845.50K
-
917.50K
8.52%
621.50K
32.26%
229.50K
63.07%
15M
-
15M
0%
book value per share
-2.44
-
-3.18
30.28%
5.82
283.11%
0.38
93.44%
1.80
371.58%
3.71
106.01%
1.72
53.50%
0.98
43.01%
capex per share
-0.04
-
-0.06
75.12%
-0.10
53.42%
-0.06
37.43%
-0.01
76.61%
-0.01
44.70%
-0.01
19.34%
-0.02
155.51%
capex to depreciation
-2.08
-
-1.65
20.59%
-1.23
25.58%
-1.09
11.51%
-0.49
55.41%
-0.47
3.63%
-0.76
61.83%
-2.37
212.71%
0.71
129.97%
capex to operating cash flow
0.06
-
-0.03
153.42%
0.03
178.04%
0.02
7.35%
0.01
64.01%
0.01
29.09%
0.00
26.90%
0.04
861.49%
0.01
71.16%
capex to revenue
-0.06
-
-0.04
27.93%
-0.07
51.27%
-0.13
98.50%
-0.01
88.89%
-0.57
3,877.36%
-15.07
2,538.01%
-0.08
99.45%
-0.06
28.83%
cash per share
0.66
-
5.73
769.58%
9.54
66.44%
3.04
68.09%
2.29
24.65%
4.15
80.82%
2.52
39.23%
4.62
83.19%
days of inventory on hand
days payables outstanding
days sales outstanding
22.55
-
15.24
32.42%
16.31
7.02%
15.81
3.04%
411.95
-
debt to assets
0.07
-
0.06
16.04%
0.19
205.57%
0.11
41.38%
0.15
37.02%
debt to equity
0.10
-
0.07
26.71%
0.31
331.60%
0.39
25.75%
0.91
131.10%
dividend yield
0.00
-
0.00
82.53%
0.00
325.16%
earnings yield
-0.07
-
-0.06
16.61%
-0.20
250.29%
-0.68
248.96%
-0.11
84.04%
-0.05
50.49%
-0.39
613.31%
-0.38
1.88%
enterprise value
233.37M
-
144.61M
38.04%
170.94M
18.21%
34.34M
79.91%
194.62M
466.79%
1.40B
618.11%
299.24M
78.59%
304.40M
1.72%
-140.93M
146.30%
enterprise value over ebitda
-14.55
-
-10.98
24.49%
-4.42
59.77%
-0.52
88.16%
-6.96
1,230.26%
-16.12
131.76%
-1.77
89.01%
-1.49
15.70%
0.82
154.95%
ev to operating cash flow
-24.22
-
4.58
118.90%
-4.01
187.49%
-0.62
84.47%
-2.87
361.97%
-18.71
551.27%
-2.14
88.58%
-6.17
188.48%
0.83
113.53%
ev to sales
22.53
-
5.74
74.50%
9.74
69.59%
3.24
66.73%
4.62
42.55%
1.69K
36,432.37%
6.96K
312.29%
11.45
99.84%
-3.82
133.39%
free cash flow per share
-0.59
-
1.74
397.45%
-3.64
309.03%
-2.46
32.60%
-1.57
36.03%
-1.22
22.21%
-1.99
62.98%
-0.55
72.37%
free cash flow yield
-0.04
-
0.12
397.45%
-0.22
278.11%
-0.60
171.43%
-0.27
54.45%
-0.05
83.25%
-0.32
597.26%
-0.09
70.67%
graham net net
-2.58
-
-3.41
32.23%
4.54
233.25%
-0.06
101.26%
1.62
2,933.77%
3.41
110.28%
1.33
61.14%
2.27
71.35%
graham number
7.18
-
7.49
4.23%
20.54
174.36%
4.90
76.16%
5.03
2.81%
10.95
117.64%
9.65
11.95%
7.00
27.42%
income quality
0.59
-
-2.31
493.09%
1.10
147.82%
0.86
22.07%
2.40
179.48%
0.85
64.67%
0.82
2.97%
0.24
70.63%
0.98
306.98%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
interest coverage
-124.87
-
-244.25
95.61%
-133.95
45.16%
-61.51
54.08%
42.15
168.53%
interest debt per share
0.18
-
0.28
49.74%
0.56
102.94%
0.42
24.28%
inventory turnover
invested capital
0.10
-
0.07
26.71%
0.31
331.60%
0.39
25.75%
0.91
131.10%
market cap
244.90M
-
244.90M
0%
197.53M
19.34%
93.97M
52.43%
249.21M
165.20%
1.64B
556.52%
439.01M
73.17%
548.81M
25.01%
net current asset value
-44.35M
-
-58.53M
31.99%
56.82M
197.08%
424K
99.25%
72.10M
16,905.42%
213.27M
195.78%
104.53M
50.99%
76.94M
26.40%
24.90M
67.63%
net debt to ebitda
0.72
-
7.62
959.66%
0.69
90.98%
0.91
32.15%
1.95
114.84%
2.75
41.02%
0.83
69.92%
1.20
44.91%
0.82
31.56%
net income per share
-0.94
-
-0.78
16.61%
-3.22
311.09%
-2.79
13.34%
-0.63
77.59%
-1.44
129.93%
-2.40
66.73%
-2.22
7.56%
operating cash flow per share
-0.55
-
1.81
427.81%
-3.55
296.59%
-2.40
32.47%
-1.56
35.03%
-1.21
22.01%
-1.98
63.26%
-0.53
73.43%
payables turnover
receivables turnover
16.19
-
23.95
47.97%
22.38
6.56%
23.08
3.14%
0.89
-
research and ddevelopement to revenue
2.06
-
1.27
38.31%
2.66
109.32%
5.66
112.48%
1.31
76.90%
80.96
6,096.10%
3.07K
3,692.02%
6.52
99.79%
4.02
38.32%
return on tangible assets
-1.14
-
-0.13
88.57%
-0.30
127.14%
-0.82
176.42%
-0.25
69.10%
-0.32
27.86%
-0.82
153.88%
-0.62
24.39%
-0.76
22.34%
revenue per share
0.59
-
1.44
142.99%
1.46
1.42%
0.46
68.48%
0.97
110.56%
0.01
98.61%
0.00
95.48%
0.28
46,486.80%
roe
0.38
-
0.25
35.99%
-0.55
324.51%
-7.31
1,221.16%
-0.35
95.25%
-0.39
11.61%
-1.39
258.60%
-2.25
62.21%
-4.65
106.34%
roic
0.38
-
0.25
35.07%
-0.57
327.77%
-7.63
1,247.59%
-0.32
95.85%
-0.34
8.52%
-0.97
183.32%
-1.49
52.94%
-2.17
46.08%
sales general and administrative to revenue
0.52
-
0.28
46.25%
0.60
114.91%
1.54
158.57%
0.41
73.39%
26.45
6,346.94%
857.86
3,143.12%
2.14
99.75%
1.62
24.61%
shareholders equity per share
-2.44
-
-3.18
30.28%
5.82
283.11%
0.38
93.44%
1.80
371.58%
3.71
106.01%
1.72
53.50%
0.98
43.01%
stock based compensation to revenue
0.03
-
0.03
21.23%
0.08
205.40%
0.37
352.35%
0.12
68.45%
8.66
7,388.97%
428.12
4,842.56%
0.81
99.81%
0.57
29.17%
tangible asset value
-42.69M
-
-55.62M
30.28%
69.99M
225.85%
8.79M
87.43%
78.32M
790.48%
228.09M
191.23%
121.74M
46.63%
92.06M
24.38%
36.90M
59.91%
tangible book value per share
-2.44
-
-3.18
30.28%
5.82
283.11%
0.38
93.44%
1.80
371.58%
3.71
106.01%
1.72
53.50%
0.98
43.01%
working capital
2.02M
-
73.79M
3,554.63%
85.66M
16.09%
706K
99.18%
77.26M
10,842.78%
228.58M
195.87%
141.38M
38.15%
227.69M
61.05%
150.42M
33.94%

All numbers in USD (except ratios and percentages)